Use of a comprehensive geriatric assessment for the management of elderly patients with advanced non-small cell lung cancer: The Phase III randomized ESOGIA-GFPC-GECP 08-02 Study

Journal of Clinical Oncology

Volumn 34, Issue 13, 2016, Pages 1476-1483

  Corre, Romain ^a   Greillier, Laurent ^b   Le Caër, Hervé ^c   Audigier Valette, Clarisse ^d   Baize, Nathalie ^f   Bérard, Henri ^e   Falchero, Lionel ^g   Monnet, Isabelle ^h   Dansin, Eric ⁱ   Vergnenègre, Alain ^j   Marcq, Marie ^k   Decroisette, Chantal ^l   Auliac, Jean Bernard ^m   Bota, Suzanna ⁿ   Lamy, Régine ^o   Massuti, Bartomeu ^t   Dujon, Cécile ^p   Pérol, Maurice ^q   Daurès, Jean Pierre ^r   Descourt, Renaud ^s   Léna, Hervé ^a   Plassot, Carine ^r   Chouaïd, Christos ^h   more..

^a RENNES UNIVERSITY HOSPITAL   (France)

^b Université de Médecine   (France)

^c Centre Hospitalier de Draguignan   (France)

^d Centre Hospitalier Intercommunal Toulon La Seyne sur Mer   (France)

^e Department of Hematology   (France)

^f ANGERS UNIVERSITY HOSPITAL   (France)

^g Centre Hospitalier de Villefranche sur Saone   (France)

^h CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

ⁱ CENTRE OSCAR LAMBRET   (France)

^j LIMOGES UNIVERSITY HOSPITAL   (France)

^k Centre hospitalier Les Oudairies   (France)

^l Centre Hospitalier de la Region d'Annecy   (France)

^m Centre Hospitalier de Mantes La Jolie   (France)

ⁿ HÔPITAL CHARLES NICOLLE   (France)

^o Centre Hospitalier de Bretagne Sud   (France)

^p CENTRE HOSPITALIER DE VERSAILLES   (France)

^q CENTRE LÉON BÉRARD   (France)

^r UNIV MONTPELLIER   (France)

^s BREST UNIVERSITY HOSPITAL   (France)

^t HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; DOCETAXEL; GEMCITABINE; PEMETREXED; ANTINEOPLASTIC AGENT; DEOXYCYTIDINE; PACLITAXEL; TAXOID;

ADVANCED CANCER; AGED; ANOREXIA; ARTICLE; ASTHENIA; BEST SUPPORTIVE CARE; BODY MASS; CANCER COMBINATION CHEMOTHERAPY; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CHARLSON COMORBIDITY INDEX; COMPREHENSIVE GERIATRIC ASSESSMENT; CONTROLLED STUDY; DRUG TREATMENT FAILURE; FAILURE FREE SURVIVAL; FEBRILE NEUTROPENIA; FEMALE; GERIATRIC ASSESSMENT; GERIATRIC DISORDER; GROUPS BY AGE; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; NEUTROPENIA; NON SMALL CELL LUNG CANCER; OPEN STUDY; OVERALL SURVIVAL; PATIENT CARE; PERIPHERAL NEUROPATHY; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SENSORY NEUROPATHY; SMOKING; SQUAMOUS CELL LUNG CARCINOMA; SYSTEMIC THERAPY; THROMBOCYTOPENIA; TREATMENT FAILURE FREE SURVIVAL; TREATMENT RESPONSE; ANALOGS AND DERIVATIVES; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CLINICAL TRIAL; FOLLOW UP; LUNG NEOPLASMS; PATHOLOGY; PROGNOSIS; SURVIVAL RATE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; DEOXYCYTIDINE; FEMALE; FOLLOW-UP STUDIES; GERIATRIC ASSESSMENT; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASM STAGING; PACLITAXEL; PEMETREXED; PROGNOSIS; QUALITY OF LIFE; SURVIVAL RATE; TAXOIDS;

EID: 84968764061     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2015.63.5839     Document Type: Article

References (34)

1. Ferlay J, Shin H-R, Bray F, et al: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893-2917, 2010
2. Altekruse S, Kosary S, Krapcho M., et al: SEER cancer statistics review, 1975-2007. http://seer.cancer.gov/archive/csr/1975-2007/
3. The Elderly Lung Cancer Vinorelbine Italian Study Group: Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small-cell lung cancer. J Natl Cancer Inst 91:66-72, 1999
4. Gridelli C, Maione P, Illiano A., et al: Cisplatin plus gemcitabine or vinorelbine for elderly patients with advanced non small-cell lung cancer: The MILES-2P studies. J Clin Oncol 25:4663-4669, 2007
5. Pfister DG, Johnson DH, Azzoli C.G., et al; American Society of Clinical Oncology: American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: Update 2003. J Clin Oncol 22:330-353, 2004
6. Azzoli CG, Baker S Jr, Temin S, et al; American Society of Clinical Oncology: American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer. J Clin Oncol 27:6251-6266, 2009
7. Belani CP, Fossella F: Elderly subgroup analysis of a randomized phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for first-line treatment of advanced nonsmall cell lung carcinoma (TAX 326). Cancer 104:2766-2774, 2005
8. Ansari RH, Socinski MA, Edelman M.J., et al; Alpha Oncology Research Network: A retrospective analysis of outcomes by age in a three-arm phase III trial of gemcitabine in combination with carboplatin or paclitaxel vs. paclitaxel plus carboplatin for advanced non-small cell lung cancer. Crit Rev Oncol Hematol 78:162-171, 2011
9. Quoix E, Zalcman G, Oster J-P, et al; Intergroupe Francophone de Cancérologie Thoracique: Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial. Lancet 378: 1079-1088, 2011
10. Pallis AG, Gridelli C, Wedding U., et al: Management of elderly patients with NSCLC; updated expert's opinion paper: EORTC Elderly Task Force, Lung Cancer Group and International Society for Geriatric Oncology. Ann Oncol 25:1270-1283, 2014
11. Extermann M, Hurria A: Comprehensive geriatric assessment for older patients with cancer. J Clin Oncol 25:1824-1831, 2007
12. Girre V, Falcou M-C, Gisselbrecht M, et al: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? J Gerontol A Biol Sci Med Sci 63:724-730, 2008
13. Balducci L, Extermann M: Management of cancer in the older person: A practical approach. Oncologist 5:224-237, 2000
14. LeCaer H, Barlesi F, Robinet G., et al: An open multicenter phase II trial of weekly docetaxel for advanced-stage non-small-cell lung cancer in elderly patients with significant comorbidity and/or poor performance status: The GFPC 02-02b study. Lung Cancer 57:72-78, 2007
15. LeCaer H, Fournel P, Jullian H., et al: An open multicenter phase II trial of docetaxel-gemcitabine in Charlson score and performance status (PS) selected elderly patients with stage IIIB pleura/IV non-small cell lung cancer (NSCLC): The GFPC 02-02a study. Crit Rev Oncol Hematol 64:73-81, 2007
16. LeCaer H, Greillier L, Corre R., et al; GFPC 0505 Team: A multicenter phase II randomized trial of gemcitabine followed by erlotinib at progression, versus the reverse sequence, in vulnerable elderly patients with advanced non small-cell lung cancer selected with a comprehensive geriatric assessment (the GFPC 0505 study). Lung Cancer 77:97-103, 2012
17. LeCaer H, Barlesi F, Corre R., et al; GFPC 0504 Team: A multicentre phase II randomised trial of weekly docetaxel/gemcitabine followed by erlotinib on progression, vs the reverse sequence, in elderly patients with advanced non small-cell lung cancer selected with a comprehensive geriatric assessment (the GFPC 0504 study). Br J Cancer 105:1123-1130, 2011
18. Wildiers H, Heeren P, Puts M., et al: International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer. J Clin Oncol 32:2595-2603, 2014
19. Puts MTE, Santos B, Hardt J., et al: An update on a systematic review of the use of geriatric assessment for older adults in oncology. Ann Oncol 25:307-315, 2014
20. Kudoh S, Takeda K, Nakagawa K., et al: Phase III study of docetaxel compared with vinorelbine in elderly patients with advanced non-small-cell lung cancer: Results of the West Japan Thoracic Oncology Group Trial (WJTOG 9904). J Clin Oncol 24: 3657-3663, 2006
21. Karampeazis A, Vamvakas L, Agelidou A., et al: Docetaxel vs. vinorelbine in elderly patients with advanced non-small-cell lung cancer: A hellenic oncology research group randomized phase III study. Clin Lung Cancer 12:155-160, 2011
22. Fairclough DL: Design and Analysis of Quality of Life Studies in Clinical Trials. Boca Raton, FL, CRC Press, 2010
23. Crowley J, Hoering A: Handbook of Statistics in Clinical Oncology. Boca Raton, FL, CRC Press, 2012 doi:10.1201/b11800
24. Wildiers H, Mauer M, Pallis A., et al: End points and trial design in geriatric oncology research: A joint European Organisation for Research and Treatment of Cancer Alliance for Clinical Trials in Oncology International Society of Geriatric Oncology position article. J Clin Oncol 31:3711-3718, 2013
25. Frasci G, Lorusso V, Panza N., et al: Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small-cell lung cancer. J Clin Oncol 18:2529-2536, 2000
26. Asmis TR, Ding K, Seymour L., et al; National Cancer Institute of Canada Clinical Trials Group: Age and comorbidity as independent prognostic factors in the treatment of non small-cell lung cancer: A review of National Cancer Institute of Canada Clinical Trials Group trials. J Clin Oncol 26: 54-59, 2008
27. Repetto L, Fratino L, Audisio R.A., et al: Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: An Italian Group for Geriatric Oncology Study. J Clin Oncol 20:494-502, 2002
28. Maione P, Perrone F, Gallo C., et al: Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: A prognostic analysis of the multicenter Italian lung cancer in the elderly study. J Clin Oncol 23:6865-6872, 2005
29. Kanesvaran R, Li H, Koo K-N, et al: Analysis of prognostic factors of comprehensive geriatric assessment and development of a clinical scoring system in elderly Asian patients with cancer. J Clin Oncol 29:3620-3627, 2011
30. Aaldriks AA, Maartense E, le Cessie S, et al: Predictive value of geriatric assessment for patients older than 70 years, treated with chemotherapy. Crit Rev Oncol Hematol 79:205-212, 2011
31. Zhu J, Sharma DB, Chen A.B., et al: Comparative effectiveness of three platinum-doublet chemotherapy regimens in elderly patients with advanced non-small cell lung cancer. Cancer 119: 2048-2060, 2013
32. Quoix E, Breton J-L, Ducoloné A, et al: First line chemotherapy with gemcitabine in advanced non-small cell lung cancer elderly patients: A randomized phase II study of 3-week versus 4-week schedule. Lung Cancer 47:405-412, 2005
33. Gridelli C, Perrone F, Gallo C., et al; MILES Investigators: Chemotherapy for elderly patients with advanced non-small-cell lung cancer: The Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial. J Natl Cancer Inst 95: 362-372, 2003
34. Zukin M, Barrios CH, Pereira J.R., et al: Randomized phase III trial of single-agent pemetrexed versus carboplatin and pemetrexed in patients with advanced non-small-cell lung cancer and Eastern Cooperative Oncology Group performance status of 2. J Clin Oncol 31:2849-2853, 2013